logo

For the Inventor, By the Inventor

East Lyme, CT, United States of America

James R Hauske

This inventor holds 15 USPTO granted patents. Top assignee: Pfizer Corporation. Active years: 1982-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: James R Hauske. Retrieved from https://idiyas.com/inventor/james-r-hauske-9uzfs3hd

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 15

% Patents Active = 100.0

Average Co-Inventor Count = 1.9

ph-index = 5

Forward Citations = 87(Granted Patents)


Location History:

  • Groton, CT (US) (1991)
  • New York, NY (US) (1990 - 1994)
  • East Lyme, CT (US) (1982 - 1996)
  • Marlboro, MA (US) (2004)

Company Filing History:

goldMedal15 out of 4,489 
 
Pfizer Corporation
 patents

Years Active: 1982-2004

Loading Chart...
15 patents (USPTO):Explore Patents
1. 6756388 - Benzothiophenes and related compounds as estrogen agonists (2004-06-29),
2. 5563135 - Desosamino derivatives of macrolides (1996-10-08),
3. 5506233 - Desosamino derivatives of macrolides as immunosuppressants and (1996-04-09),
4. 5359060 - Phosponated derivatives of macrolides (1994-10-25),
5. 5064855 - Acid polycyclic ether antibiotic (1991-11-12),
6. 4956283 - Process for preparing macrolide antibiotics by culturing streptomyces (1990-09-11),
7. 4920050 - Acidic polycyclic ether antibiotic (1990-04-24),
8. 4857641 - C.12 modified erythromycin A derivatives (1989-08-15),
9. 4835141 - Neutral macrolide antibiotics from Streptomyces (1989-05-30),
10. 4518590 - 9.alpha.-Aza-9.alpha.-homoerythromycin compounds, pharmaceutical (1985-05-21),
11. 4512982 - 9.alpha.-Aza-9.alpha.-homoerythromycin compounds, pharmaceutical (1985-04-23),
12. 4465674 - Azahomoerythromycin D derivative and intermediates therefor (1984-08-14),
13. 4413119 - Semi-synthetic macrolides (1983-11-01),
14. 4382086 - 9-Dihydro-11,12-ketal derivatives of erythromycin A and epi-erythromycin (1983-05-03),
15. 4363803 - 3',4'-Oxyallylene erythromycin and oleandomycin, composition and method (1982-12-14),

Title: A Spotlight on Inventor James R. Hauske

Introduction

James R. Hauske, hailing from East Lyme, Connecticut, has made significant contributions to the field of pharmaceuticals with his inventive prowess. With a commendable portfolio of 15 patents, Hauske's work primarily focuses on innovative compounds that offer therapeutic solutions for various medical conditions.

Latest Patents

Among his notable achievements, Hauske's latest patents include a series of benzothiophenes and related compounds recognized as estrogen agonists. He has also developed desosamino derivatives of macrolides and innovative macrolides designed to combat resistance in transplantation, as well as to treat fungal infections and autoimmune diseases, such as rheumatoid arthritis and psoriasis. His inventive formulations include complex specifications, such as where "n" is 1 or 2, and multiple functional groups that enhance the efficacy of these macrolides in medical applications.

Career Highlights

James R. Hauske works at Pfizer Corporation, a leading global biopharmaceutical company dedicated to health improvements. His role at Pfizer has enabled him to collaborate on groundbreaking therapeutic developments, which aim to advance treatment options in healthcare.

Collaborations

Throughout his career, Hauske has had the opportunity to collaborate with esteemed colleagues, including Walter P. Cullen and Hiroshi Maeda. These collaborations highlight the importance of teamwork within the innovative landscape of pharmaceutical research, allowing for the amalgamation of diverse insights to drive forward the frontiers of medicine.

Conclusion

In summary, James R. Hauske exemplifies the spirit of innovation through his significant contributions and active role in the pharmaceutical industry. His extensive patent portfolio not only underscores his inventive capabilities but also promises to impact the treatment of complex medical conditions positively. His work at Pfizer Corporation is a testament to his commitment to advancing medical science and improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…